Home » China Aligns Drug GMP With Global Standards, US FDA, Drugmakers Applaud Move
China Aligns Drug GMP With Global Standards, US FDA, Drugmakers Applaud Move
September 16, 2010
The U.S. Food and Drug Administration (FDA) and drugmakers are praising a new good manufacturing practice (GMP) regulation released by China’s State Food and Drug Administration (SFDA), saying it should help to boost confidence in the quality of drugs coming from China.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor